Haleon (NYSE:HLN) is without doubt one of the most promising shares below $20. On February 25, Haleon reported monetary efficiency for the full-year 2025, marked by the introduction of its ‘Win as One’ technique and an natural income development of three%. Whereas ends in North America had been tempered by low shopper confidence and a weak chilly and flu season, the corporate noticed sturdy growth in its EMEA, Latin America, and Asia-Pacific areas.
Complete income reached £11.03 billion, supported by the Oral Well being sector, which outperformed with ~8% natural development. These outcomes allowed the corporate to keep up or acquire market share in 60% of its enterprise segments. Profitability was pushed by aggressive productiveness initiatives, together with a 26% discount in SKU complexity and optimized logistics. Regardless of market challenges, the corporate continued to reinvest in its future, growing spending on R&D by 7.7%.
For 2026, Haleon (NYSE:HLN) expects natural income development to speed up to between 3% and 5%, supported by a brand new working mannequin designed to extend agility. The corporate has created a Chief Development Officer position and restructured into six particular working models to higher seize regional alternatives. Administration plans to ship excessive single-digit adjusted working revenue development and has allotted £500 million for share buybacks within the coming 12 months.
Haleon (NYSE:HLN), along with its subsidiaries, researches, develops, manufactures, and sells numerous shopper healthcare merchandise in North America, Europe, the Center East, Africa, Latin America, and the Asia Pacific.
Whereas we acknowledge the potential of HLN as an funding, we consider sure AI shares supply higher upside potential and carry much less draw back threat. Should you’re on the lookout for a particularly undervalued AI inventory that additionally stands to learn considerably from Trump-era tariffs and the onshoring pattern, see our free report on the finest short-term AI inventory.
READ NEXT: 40 Most Standard Shares Amongst Hedge Funds Heading Into 2026 and 33 Shares That Ought to Double in 3 Years.
Disclosure: None. Comply with Insider Monkey on Google Information.
![[Vantage Point] SEC’s time period limits on dealer administrators: Why it issues](https://www.rappler.com/tachyon/2026/03/Vantage-Point-SEC-broker-director-limits-March-9-2026.jpg "[Vantage Point] SEC’s time period limits on dealer administrators: Why it issues")
